Search Results

Employee Spotlight: Hu Liu, PhD

Employee Spotlight: Hu Liu, PhD

Employee Spotlight Our employee spotlight series celebrates the accomplishments and expertise of our valued scientists and staff. Hu Liu Hu Liu, PhD Director of Biologics Discovery Q&A with Dr. Liu What is your favorite part of your role here as Director of...

Employee Spotlight: Yan Wang, PhD

Employee Spotlight: Yan Wang, PhD

Employee Spotlight Our employee spotlight series celebrates the accomplishments and expertise of our valued scientists and staff. Yan Wang, PhD Yan Wang, PhD Director, Peptide Chemistry Q&A with Yan What is your favorite part of your role here as a Director of...

Exciting Upcoming Events: 2023

Exciting Upcoming Events: 2023

Throughout the year, ChemPartner attends events and conferences around the world not only to stay up to date with the latest trends but to share our expertise with the industry. Mark your calendar with this year's top biopharma conferences and events, and be sure to...

Employee Spotlight: Neha Yevalekar

Employee Spotlight: Neha Yevalekar

Employee Spotlight Our employee spotlight series celebrates the accomplishments and expertise of our valued scientists and staff. Neha Yevalakar Neha Yevalekar Senior Scientist at ChemPartner Q&A with Neha What is your favorite part of your role here as a Senior...

Antibody Generation: Single B Cell Cloning vs. Hybridoma

Antibody Generation: Single B Cell Cloning vs. Hybridoma

PD-L1 is a key inhibitor of T cell activation that is often over-expressed in cancer to escape immune surveillance and promote tumor progression. Blocking antibodies against PD-L1 or its receptor, PD-1, have shown significant clinical benefit in some patients with...